Regulatory Advances and Real-World Evidence: Accelerating SNA Adoption for Cessation Success
 
 
 

Welcome to Redefining Smoking Cessation!
 
 
 
 
Dear Esteemed Doctors,

As we advance our series on Redefining Smoking Cessation, this September edition delves into pioneering innovations in harm reduction, spotlighting emerging technologies and fresh evidence for Safer Novel Alternatives (SNAs). Our mission is to arm you with the most current, science-driven insights to empower personalized cessation strategies for your patients. Join us in exploring the transformative potential of these advancements.
 
 
 
 
 
Safer Novel Alternatives: Essential Tools for Effective Smoking Cessation

 

 
 

Safer Novel Alternatives (SNAs) like heated tobacco products and nicotine pouches reduce toxicant intake by 70-95% compared to smoking. When paired with counselling, SNAs can boost quit rates by up to 50%, outperforming nicotine replacement therapies (15-20% success). In India, where 267 million adults use tobacco, SNAs offer a harm reduction approach, potentially averting millions of premature deaths by enabling gradual nicotine weaning and higher quit attempts. This approach can significantly impact public health.
 
 
 
In the News: Global Regulatory Trends
 
 

• Australia has approved Nicorette QuickMist (a nicotine mouth spray) specifically for vaping cessation. Clinically, it reduced vaping frequency by 50% in 80% of users (The Australian).
• WHO warns that aggressive marketing of vapes and similar SNAs may reverse gains in tobacco control—especially among youth—urging stronger global regulation (The Guardian).
• FDA Authorizes ZYN Pouches (January 16, 2025): The U.S. FDA approved 20 ZYN nicotine pouch variants after rigorous review, affirming their potential in harm reduction strategies.
• Global War on Safer Alternatives (May 6, 2025): Amid legislative restrictions, experts warn that bans on SNAs could hinder public health progress in reducing smoking-related deaths.
• Heated Herbal Product Evaluation (May 28, 2025): A study on iSENZIA™ demonstrates reduced toxin delivery compared to cigarettes, positioning it as a novel aid for smokers seeking alternatives.
• Nicotine Pouch Sales Surge (July 24, 2025): U.S. data reveals a 207% increase in nicotine pouch sales from 2023 to 2025, highlighting their growing role in adult cessation amid declining cigarette use.
 
 
 
Research Summary: Evidence-Based SNA Benefits
 
• The Global State of Tobacco Harm Reduction Report (2024) shows global vaper numbers rose from 58 million (2018) to 114 million (2023), while cigarette sales declined ~9% since 2015. Safer nicotine product sales ballooned nearly sixfold to US$96 billion in 2024 (ECigIntelligence).
• A report in Respiratory Therapy links the rise in products like vapes, snus, and nicotine pouches to potential reductions in smoking-related mortality, with over two-thirds of the global population legally accessing such products (Respiratory Therapy).
 
 
 
 
Global Success Stories & Key Insights
 
 
 
 
India’s Path Forward: Balanced & Informed Regulation
 
• Currently, India bans ENDS (e-cigarettes/HTPs), under the Prohibition of Electronic Cigarettes Act, 2019 (ippr.in).
• Meanwhile, the Tobacco Control Scale (TCS) ranks India at 65/100—strong in warning labels but weak in public awareness spending and cigarette pricing (PMC).
• Experts argue for revisiting bans and pursuing a regulated harm-reduction strategy. For instance, Japan's adoption of HTPs led to a 42.4% decline in cigarette sales—a compelling model to study (The Statesman).
 
 
India's Imperative: Adopting SNAs to Tackle Smoking Challenges
 
 
India's 29% adult tobacco use contributes to 1.35 million annual deaths. Regulating Safer Novel Alternatives (SNAs) alongside education and taxes could reduce mortality risks by 60% and save 1 million lives by 2030. A balanced approach can effectively reduce tobacco-related harm in India.
 
 
 
 
You are receiving this email because you have subscribed to receive updates from us.
Should you wish to cancel your subscription, please click here to unsubscribe.